Mitosis Pharmaceuticals Private Limited
About Mitosis Pharmaceuticals Private Limited
Data last updated:
Mitosis Pharmaceuticals Private Limited is a private limited company based in Kanpur, Uttar Pradesh, India. It operates in the service-based operations segment of the business services sector. It was incorporated on 21 December 2016 and has been in existence for over 10 years.
The company is registered with the Registrar of Companies (ROC), Uttar Pradesh, under CIN U74999UP2016PTC088532. The company has 1 GST registration on record, which is no longer active.
The company has an authorised share capital of ₹10 Lakh and a paid-up capital of ₹1 Lakh. It is led by directors Amar Jeet Singh and Gurpreet Kaur.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at 125/13 – 37 38 41 Lal Quarter, Kanpur, Uttar Pradesh, India – 208006.
As per the financials filed for FY 2025, the company reported a revenue of ₹59,685, reflecting significant growth compared to the previous year. For the same year it recorded a net loss of ₹25,095 (net margin -42%) and EBITDA of -₹24,515 (EBITDA margin -41.1%).
The current compliance status is marked as compliant by the Registrar of Companies.
Company details
Contact details
Mitosis Pharmaceuticals Private Limited's registered office is in Kanpur, Uttar Pradesh. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Registered Address125/13 – 37 38 41 Lal Quarter, Kanpur, Uttar Pradesh, India – 208006
- IndustryBusiness Services, Other Services, Miscellaneous Business Activities
To see the full contact details of Mitosis Pharmaceuticals Private Limited, buy the company report.
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Business activity
The main business activity of Mitosis Pharmaceuticals is trade. In detail, this covers wholesale trading.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| G | Trade | G1 | Wholesale Trading |
To see the full business activity and turnover split of Mitosis Pharmaceuticals Private Limited, buy the company report.
Financials of Mitosis Pharmaceuticals Private Limited
FY 2025 filings availableMitosis Pharmaceuticals Private Limited reported revenue of ₹59,685 (up 186% YoY) for FY 2025.
Compounded Annual Growth Rate (CAGR)
Revenue rose 186% in the latest year. EBITDA fell 300% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | -₹24,515 | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | -₹25,095 | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | -41.1% | ||||
| Net Profit Margin | -42% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Mitosis Pharmaceuticals Private Limited, buy the company report.
Board of directors of Mitosis Pharmaceuticals Private Limited
Mitosis Pharmaceuticals has 2 current directors and 2 former directors. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Amar Jeet Singh | Director | 21 Dec 2016 | 9 Years 10 Months | Current |
| Gurpreet Kaur | Director | 09 Jan 2019 | 7 Years 9 Months | Current |
Auditor
Mitosis Pharmaceuticals Private Limited is audited by PRATHAM SINGH for the financial year 2017.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| PRATHAM SINGH | FY 2017 | 435288 |
Shareholding
The shareholding of Mitosis Pharmaceuticals Private Limited is on record for FY 2017, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2017 |
|---|---|
| Promoters | |
| Domestic institutional investors (DII) | |
| Foreign institutional investors (FII) | |
| Public | |
| Others |
To see the full shareholding pattern of Mitosis Pharmaceuticals Private Limited, buy the company report.
Legal cases
No court or tribunal cases involving Mitosis Pharmaceuticals Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Mitosis Pharmaceuticals Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
Mitosis Pharmaceuticals has 1 GST registration on record, and it has been cancelled or is inactive. Only active GST numbers are listed on this page.
To see the full GST registrations and return filing status of Mitosis Pharmaceuticals Private Limited, buy the company report.
Recent activity
Mitosis Pharmaceuticals Private Limited has 4 board changes on record since 2016: 2 appointments and 2 cessations. The latest: Raghubir Singh ceased to be Director on 05 Sep 2023.
Frequently asked questions
Mitosis Pharmaceuticals is an active private limited company based in Kanpur, Uttar Pradesh, India. The company works in other services, within the business services industry. It was incorporated on 21 December 2016 (10+ years old) and is registered under CIN U74999UP2016PTC088532.
Mitosis Pharmaceuticals has 2 current directors:
- Amar Jeet Singh - Director
- Gurpreet Kaur - Director
The latest financial statements of Mitosis Pharmaceuticals on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from FY 2017 are in the company report.
No. Mitosis Pharmaceuticals has 1 GST registration on record and it is cancelled or inactive.
The CIN (Corporate Identification Number) of Mitosis Pharmaceuticals is U74999UP2016PTC088532. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Mitosis Pharmaceuticals was incorporated on 21 December 2016, making it 10+ years old. It is registered with the Registrar of Companies, Uttar Pradesh.
Raghubir Singh ceased to be Director on 05 Sep 2023. Gurpreet Kaur ceased to be Additional Director on 30 Sep 2019. Gurpreet Kaur was appointed as Director on 09 Jan 2019. Mitosis Pharmaceuticals has 4 board changes on record in total.
The registered office of Mitosis Pharmaceuticals is at 12513 – 37 38 41 Lal Quarter, Kanpur, Uttar Pradesh, India – 208006.
Mitosis Pharmaceuticals operates in the business services industry, in the other services segment.
The compliance status of Mitosis Pharmaceuticals is compliant as of 25 July 2026. The company is actively filing with the Registrar of Companies.